In mice without adiponectin, hepatic insulin resistance was observed in parallel with a decrease in therapeutic response to agonists of PPARγ, indicating that adiponectin is an important factor enhancing PPARγ-mediated improvement in insulin sensitivity [37]. The gene discussed is INS; the disease is Insulin resistance.